Wenyan Fu

3.1k citations
57 papers · 2.2k indexed · 1 hit paper · h-index 23

Impact in

Papers in

Wenyan Fu

55 papers receiving 2.1k citations

Hit Papers

CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity 2019 · 389 citations
3892019202620212023100200300

Peers

Wenyan Fu
Comparison fields: 5 of 127
  • Cancer Research 372
  • Oncology 502
  • Immunology 371
  • Geriatrics and Gerontology 66
  • Infectious Diseases 299
Replace Ke Jiang with:
Ke Jiang China
Xiaochun Wang China
Richard Hill United States
Bing Yang China
Farhat L. Khanim United Kingdom
Bo Huang China
Liwei Dong China
Jaehong Kim South Korea
Yingjie Xu China
Wenyan Fu relative to Ke Jiang China Ke Jiang's profile →
Citations per field
00.5×2.8×
Ke Jiang · 1×
Citations per year

Countries citing papers authored by Wenyan Fu

Since Specialization
Citations

This map shows the geographic impact of Wenyan Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyan Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyan Fu more than expected).

Fields of papers citing papers by Wenyan Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyan Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyan Fu. The network helps show where Wenyan Fu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wenyan Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wenyan Fu Line = papers co-authored together Wenyan Fu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20243
4 20247
5 202419
6 202418
7 20236
8 20235
9 20233
10 202212
11 202110
12 201929
13 201926
14 201814
15 2017133
16 201622
17 201466
18 201310
19 201242
20
[Research progress on effect of coumarins compounds in anti-tumor].
200811

About Wenyan Fu

Wenyan Fu is a scholar working on Animal Science and Zoology, Oncology, Radiology, Nuclear Medicine and Imaging, Reproductive Medicine and Immunology, having authored 57 papers that have together received 2.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), CAR-T cell therapy research (7 papers), Animal Nutrition and Physiology (7 papers), HER2/EGFR in Cancer Research (6 papers), Extracellular vesicles in disease (5 papers), Immunotherapy and Immune Responses (4 papers), Adipose Tissue and Metabolism (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Cancer Research (372 citations), Oncology (502 citations), Immunology (371 citations), Geriatrics and Gerontology (66 citations) and Infectious Diseases (299 citations). Wenyan Fu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Shi Hu, Changhai Lei, Kewen Qian, Min Ding, Hang Yin, Yang Liu, Li Tian, Sheng Zhang, Fangxing Lin and Xuting Ye. Their work appears in journals such as Frontiers in Immunology, Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology, Oncotarget, The FASEB Journal and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026